Form 4 for EFX Equifax
Accepted 2022-08-02 00:00:00 ET · period of report 2022-07-29 · accession 0001225208-22-009135 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-08-02 | 2022-07-29 | EFX | Begor Mark W | CEO, Dir | A - Grant | $0.00 | +23.9K | 103.8K | +30% | $0 |
| DM | 2022-08-02 | 2022-07-29 | EFX | Begor Mark W | CEO, Dir | A - Grant | $0.00 | +91.7K | 43.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-29 | A | A | 23,934 | $0.00 | 103,798 | D | — | — | (F1) Special equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock vests 100% on 12/31/2025. (F2) Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. |
| 2 | Derivative | Stock Option/Right to Buy | 2022-07-29 | A | A | 48,281 | $0.00 | 48,281 | D | $250.69 · 2025-12-31 to 2030-07-29 | 48,281 Common Stock | (F3) Special equity grant pursuant to the Company's long-term incentive plan. The option vests 100% on 12/31/2025. |
| 3 | Derivative | Stock Option/Right to Buy | 2022-07-29 | A | A | 43,440 | $0.00 | 43,440 | D | $229.80 · 2025-12-31 to 2030-07-29 | 43,440 Common Stock | (F3) Special equity grant pursuant to the Company's long-term incentive plan. The option vests 100% on 12/31/2025. |